Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Zhao, Jian  [Clear All Filters]
2013
Hu W, Zhao J, Pei G. Activation of aryl hydrocarbon receptor by Tranilast, an anti-allergy drug,promotes miR-302 expression and cell reprogramming. J Biol Chem. 2013.
2018
He K, Ma X, Xu T, Li Y, Hodge A, Zhang Q, Torline J, Huang Y, Zhao J, Ling K, et al. Axoneme polyglutamylation regulated by Joubert syndrome protein ARL13B controls ciliary targeting of signaling molecules. Nat Commun. 2018;9(1):3310.
Wang Y, Yu H, Chen Y, Li G, Lei Y, Zhao J. Derivation of induced pluripotent stem cells TUSMi006 from an 87-year old Chinese Han Alzheimer's disease patient carrying GRINB and SORL1 mutations. Stem Cell Res. 2018;31:127-130.
Wang Y, Kang C, Yu H, Fen J, Ma X, Lei Y, Zhao J. Establishment of TUSMi004-A, an induced pluripotent stem cell (iPSC) line from a 32-year old Chinese Han patient with Obsessive-Compulsive Disorder (OCD). Stem Cell Res. 2018;32:83-86.
2019
Zhao J. Corrigendum to Establishment of TUSMi005-A, an induced pluripotent stem cell (iPSC) line from a 32-year old Chinese Han patient with Bipolar Disorder (BD). Stem Cell Research 33(2018) 65-68. Stem Cell Res. 2019:101413.
Wang Y, Zhang J, Lei Y, Zhao J. Corrigendum to "Establishment of TUSMi007-A, an induced pluripotent stem cell (iPSC) line from an 83-year old Chinese Han patient with Alzheimer's disease (AD)" [Stem Cell Research 33(2018) 265-268]. Stem Cell Res. 2019:101412.
Wang Y, Zhang J, Hu J, Li G, Lei Y, Zhao J. Establishment of TUSMi008-A, an induced pluripotent stem cell (iPSC) line from a 76-year old Alzheimer's disease (AD) patient with PAXIP1 gene mutation. Stem Cell Res. 2019;36:101391.
Yin J, Hu W, Pan L, Fu W, Dai L, Jiang Z, Zhang F, Zhao J. let‑7 and miR‑17 promote self‑renewal and drive gefitinib resistance in non‑small cell lung cancer. Oncol Rep. 2019.
2020
Hekman RM, Hume AJ, Goel RKumar, Abo KM, Huang J, Blum BC, Werder RBree, Suder EL, Paul I, Phanse S, et al. Actionable Cytopathogenic Host Responses of Human Alveolar Type 2 Cells to SARS-CoV-2. Mol Cell. 2020.
Wang H, Gao L, Qi M, Su P, Xiong X, Zhao J, Hu J, Han B. BTF3 promotes stemness and inhibits TypeⅠInterferon signaling pathway in triple-negative breast cancer. Biochem Biophys Res Commun. 2020;537:22-28.
Yan YI, Qiu Y, Zhao A, Zhao J, Wang Y, Deng Y. Establishment of SIAISi001-A, an induced pluripotent stem cell (iPSC) line from 66-year old mild cognitive impairment (MCI) with two copies of APOE4 gene. Stem Cell Res. 2020;43:101702.
Yan Y, Qiu Y, Zhao A, Zhao J, Wang Y, Deng Y. Establishment of SIAISi002-A, an induced pluripotent stem cell (iPSC) line from 39-year old healthy female donor with a family history of Alzheimer's disease (AD) and two copies of APOE4 gene. Stem Cell Res. 2020;45:101792.
Dai Q, Zhang W, Guo J, Di W, Zhao J, Zhang B, Wang Y. Generation of an induced pluripotent stem cell line (SIAISi003-A) from a 79-year-old patient with Alzheimer's disease having APOE3/4 genetic background. Stem Cell Res. 2020;48:101949.
2021
Zhang W, Hua Y, Di W, Guo J, Dai Q, Zhao J, Zhang B, Wang Y. Generation of a human induced pluripotent stem cell line (SIAISi011-A) from a 61-year-old Chinese Han healthy female donor. Stem Cell Res. 2021;51:102173.
Guo J, Fang F, Dai Q, Zhang W, Di W, Hu J, Zhao J, Cao J, Wang Y. Generation of a human-derived induced pluripotent stem cell line (SIAISi012-A) from an 82-year-old healthy Chinese Han male. Stem Cell Res. 2021;52:102186.
Zhang W, Di W, Zhao J, Zhang B, Wang Y. Generation of a SIAISi004-A hiPSC line from PBMCs of a 74 year-old Alzheimer's disease woman by non-integrating sendai virus mediated reprogramming. Stem Cell Res. 2021;55:102501.
Guo J, Di W, Zhang W, Dai Q, Zhao J, Deng Y, Wang Y. Generation of an induced pluripotent stem cell line (SIAISi009-A) from a 60-year-old Chinese Han female with mild cognitive impairment (MCI) having two copies of APOE4/4 allele. Stem Cell Res. 2021;51:102198.
Zhang W, Dai Q, Hua Y, Di W, Guo J, Zhao J, Deng Y, Wang Y. Generation of three iPSC cell lines (SIAISi006-A, SIAISi007-A and SIAISi008-A) from a 66-year-old Alzheimer's disease (AD) patient and her two unaffected children from Chinese Han population. Stem Cell Res. 2021;51:102172.
2023
Fu W, Li G, Lei C, Qian K, Zhang S, Zhao J, Hu S. Bispecific antibodies targeting EGFR/Notch enhance the response to talazoparib by decreasing tumour-initiating cell frequency. Theranostics. 2023;13(11):3641-3654.
Huang J, Wang Y, Zhao J, Deng Y, Wei W. Establishment of an induced pluripotent stem cell (SIAISi016-A) line from a 62-years old Chinese Han patient with Alzheimer's disease. Stem Cell Res. 2023;69:103091.
Tanaka Y, Kadota S, Zhao J, Kobayashi H, Okano S, Izumi M, Honda Y, Ichimura H, Shiba N, Uemura T, et al. Mature human induced pluripotent stem cell-derived cardiomyocytes promote angiogenesis through alpha-B crystallin. Stem Cell Res Ther. 2023;14(1):240.
Dong X, Liao B, Zhao J, Li X, Yan K, Ren K, Zhang X, Bao X, Guo W. METTL14 mediates ma modification on osteogenic proliferation and differentiation of bone marrow mesenchymal stem cells by regulating the processing of pri-miR-873. Mol Med Rep. 2023;28(3).